Development of Combination Products: Critical Interactions - 4-Day Online Seminar (October 3-4, 2024) Covering EU/US Drug-Device Regulations, Quality Processes, Regulatory Strategy Overview
July 03, 2024 10:59 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Development of Combination Products: Critical Interactions Training Course" conference has been added to ResearchAndMarkets.com's offering. ...
Global Drug Screening Research Report 2023: Market to Reach $7.7 Billion by 2030 - Automation and High-Throughput Systems Transforming the Drug Screening Landscape
January 24, 2024 06:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Screening Market 2030 by Product, Sample, End-user Industry & Region - Partner & Customer Ecosystem Competitive Index &...
Global Dermatology CRO Market 2023-2030: Intellectual Property Challenges Pose Hurdles to Dermatology CRO Industry Growth
September 22, 2023 06:58 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical...
Orphan Drugs and Rare Diseases Conference: Life-saving Therapies, Critical Issues, and Strategies to Enhance Orphan Drug Development in near future (London, United Kingdom - October 9-10, 2023)
August 14, 2023 04:13 ET
|
Research and Markets
Dublin, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The "Orphan Drugs and Rare Diseases Conference" conference has been added to ResearchAndMarkets.com's offering. The 4th Annual Orphan Drugs and Rare...
United States Dietary Supplements Regulatory Training Course: Compliance Requirements, Product Claims, Labeling Issues and FDA Updates (November 3, 2022)
October 17, 2022 04:18 ET
|
Research and Markets
Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "US Dietary Supplements - Regulatory Compliance Requirements, Product Claims, Labeling Issues and FDA Updates Course" training has been added to ...
Global Orphan Drugs Market Report 2021-2026 Featuring Market Leaders - AbbVie, Eli Lilly, Johnson & Johnson, Merck & Co., Pfizer and Sanofi-Aventis
August 06, 2021 04:53 ET
|
Research and Markets
Dublin, Aug. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Markets for Orphan Drugs" report has been added to ResearchAndMarkets.com's offering. The Global Orphan Drug Market is Set to Grow to $191...